Dr. Yannick Delpu is a cancer biologist with a background in epigenetics. He obtained his PhD in cancer biology from the University of Toulouse, France, where he studied micro-RNA-based gene therapy at the Centre de Recherche en Cancerologie de Toulouse (CRCT). His postdoctoral training at New York University, USA, was focused on the relation between genome methylation, DNA secondary structures and genomic instability in cancer and developmental diseases. Currently, as a Scientific Affairs Manager for EMEA at Bionano Genomics, Dr. Delpu is facilitating the scientific discoveries based on Bionano platform. He is also leading clinical validation studies in genetic diseases and cancer diagnostics.